Wednesday, October 1, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

New Breast Reconstruction Surgery Information At Consumer Guide To Plastic Surgery
http://www.medicalnewstoday.com/articles/123806.php
How is breast reconstruction performed? How will the breasts look afterward? What are the risks and side effects? Will insurance pay for it? These are important questions that may be going through the minds of millions of breast cancer survivors as they consider breast reconstruction.

Anoto Digital Pen Cuts Mammogram Analysis From Hours To Minutes In France
http://www.medicalnewstoday.com/articles/123750.php
Sweden-based Anoto Group AB, the inventor of the Anoto Digital Pen and Paper technology, announces its tremendous success in reducing waiting lists for breast cancer screening by significantly shortening the time it takes to analyze mammograms.

Many Women Who Beat Cancer Don't Change Habits
http://www.medicalnewstoday.com/articles/123715.php
Many women who battle breast cancer will tell you it's a life-changing experience. However, a new study shows that for many women, the changes aren't always positive or permanent. Now the surprising results of a study that looked at the habits of women, after diagnosis.

Birth Size Is A Marker Of Susceptibility To Breast Cancer Later In Life
http://www.medicalnewstoday.com/articles/123620.php
The findings from a study by a team based at the London School of Hygiene & Tropical Medicine (LSHTM) are published today in PLoS Medicine.Associations between birth size, perhaps as a marker of the pre-natal environment, and subsequent breast cancer risk have been identified before, but the findings from epidemiological studies have been inconsistent.

Early Detection Is A Woman's Best Protection Against Breast Cancer
http://www.medicalnewstoday.com/articles/123616.php
One in four women in San Diego County are not being screened for breast cancer and are at risk for developing the deadly disease, according to Susan G. Komen for the Cure, San Diego.

----------------------------------------------
** CANCER / ONCOLOGY News **

Disease Diagnosis In Just 15 Minutes
http://www.medicalnewstoday.com/articles/123781.php
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit. A team led by scientists at the University of Leeds has developed a biosensor technology that uses antibodies to detect biomarkers - molecules in the human body which are often a marker for disease - much faster than current testing methods.

Dosing Began In TransMolecular's Phase 1/2 Clinical Trial For Intravenous Administration Of 131Iodine-TM601 In Recurrent Malignant Glioma Patients
http://www.medicalnewstoday.com/articles/123766.php
TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that dosing was initiated in a Phase 1/2 trial of 131I-TM601 delivered intravenously (IV) for the treatment of adult patients with recurrent malignant glioma.

Audit Shows Better Care For Head And Neck Cancer Patients, But Still Room For Improvement, England And Wales
http://www.medicalnewstoday.com/articles/123748.php
Head and neck cancer patients in England and Wales are receiving better care than in previous years, but there is still room for improvement, the latest National Head and Neck Cancer audit shows.

Poor Prognosis For Vulvar Cancer Signalled By Extra Copies Of EGFR Gene
http://www.medicalnewstoday.com/articles/123747.php
A genetic fingerprint identified in patients with a gynecologic cancer may reveal candidates for targeted therapy. In a study in the journal <i>Gynecologic Oncology</i>, investigators from the Massachusetts General Hospital (MGH) Obstetrics and Gynecology Service report that women with vulvar carcinoma whose tumors have extra copies of the epidermal growth factor receptor (EGFR) gene are at increased risk of dying from their cancer.

The International Myeloma Foundation Applauds Expansion Of VELCADE(R) For Previously Untreated Patients In Europe And Canada
http://www.medicalnewstoday.com/articles/123744.php
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today heralded the expansion of treatment options for previously untreated patients with multiple myeloma, giving patients in Canada and Europe access to drugs similar to what is available to patients in the United States.

Cells That Avoid Suicide May Become Cancerous
http://www.medicalnewstoday.com/articles/123738.php
When a cell's chromosomes lose their ends, the cell usually kills itself to stem the genetic damage. But University of Utah biologists discovered how those cells can evade suicide and start down the path to cancer.

A.P. Pharma Announces Positive Phase 3 Results With APF530 In The Prevention Of Chemotherapy Induced Nausea And Vomiting
http://www.medicalnewstoday.com/articles/123722.php
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, announced today positive results from its pivotal Phase 3 study comparing te efficacy of APF530 (the Company's proprietary, sustained release formulation of granisetron) with Aloxi&reg; for the prevention of chemotherapy induced nausea and vomiting (CINV).

British Lymphology Society Chooses Belfast For Prestigious Annual Conference
http://www.medicalnewstoday.com/articles/123700.php
The British Lymphology Society (BLS), the only UK body representing the medical professionals who treat lymphoedema, has chosen Belfast as the venue for its high profile annual conference. Nearly 200 nursing and physiotherapy delegates, plus 11 pharmaceutical companies will be gathering at the Wellington Park Hotel for three days; 5-7 October.

Vitamin C Supplements Affect Cancer Drugs
http://www.medicalnewstoday.com/articles/123682.php
Experiments on lab cultured cells and mice suggested that high amounts of vitamin C derivative at the cellular level, as results from taking supplements, may actually reduce the effect of anti-cancer drugs by helping the cancer cells live longer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Cervical Cancer Vaccine: 'dangers Mean More Research Is Needed'
http://www.medicalnewstoday.com/articles/123762.php
An independent health researcher is calling on the government for more research into the possible side-effects of the cervical cancer vaccine that is currently being given to teenage girls throughout the country.

HPV Vaccine Requirement For Female Immigrants Discriminatory, Advocates Say
http://www.medicalnewstoday.com/articles/123661.php
<BR />Some immigration and women's rights advocacy groups are claiming that a new <A href="http://www.uscis.gov/portal/site/uscis/menuitem.5af9bb95919f35e66f614176543f6d1a/?vgnextoid=902252b10f45b110VgnVCM1000004718190aRCRD&amp;vgnextchannel=098daca797e63110VgnVCM1000004718190aRCRD" target=_new>requirement</A> for female immigrants to receive the human papillomavirus vaccine is discriminatory, the <A href="http://www.

Cervical Cancer Screening Strategies Show Various Benefits And Drawbacks
http://www.medicalnewstoday.com/articles/123631.php
The risks and benefits of different cervical cancer preventionapproaches may aid women to work with their physicians to implement theappropriate screening strategies, as analyzed by a model, reported inan article released on September 22, 2008 in <i>Archives ofInternal Medicine</i>, one of the JAMA/Archives journals.

----------------------------------------------
** COLORECTAL CANCER News **

Understanding Cause Of Colon Cancer Takes Important Steps Forward
http://www.medicalnewstoday.com/articles/123708.php
Scientists investigating a molecule known to play a key role in causing colon cancer have made a series of ground-breaking discoveries that could have major implications for future treatment of the disease, responsible for 655,000 deaths worldwide per year.

New Option For Some Colorectal Cancer Patients
http://www.medicalnewstoday.com/articles/123701.php
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.

Colorectal Screening Generally Not Required In The Under 50's
http://www.medicalnewstoday.com/articles/123694.php
Young adults without a family history of bowel disease are unlikely to develop adenomas, the colorectal polyps most likely to lead to cancer, according to new research directed by scientists at the Johns Hopkins Kimmel Cancer Center.

Colorectal Cancer Risk Lower With Certain Gene Variation
http://www.medicalnewstoday.com/articles/123313.php
Anew study published in the October 1 issue of <i>JAMA</i>reports that decreased colorectal cancer risk is linked to variation ofa gene for a protein hormone that is secreted by fat cells.<b></b>Previous research has pointed towards a link betweencolorectal cancer risk and obesity.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

The International Myeloma Foundation Applauds Expansion Of VELCADE(R) For Previously Untreated Patients In Europe And Canada
http://www.medicalnewstoday.com/articles/123744.php
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today heralded the expansion of treatment options for previously untreated patients with multiple myeloma, giving patients in Canada and Europe access to drugs similar to what is available to patients in the United States.

British Lymphology Society Chooses Belfast For Prestigious Annual Conference
http://www.medicalnewstoday.com/articles/123700.php
The British Lymphology Society (BLS), the only UK body representing the medical professionals who treat lymphoedema, has chosen Belfast as the venue for its high profile annual conference. Nearly 200 nursing and physiotherapy delegates, plus 11 pharmaceutical companies will be gathering at the Wellington Park Hotel for three days; 5-7 October.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Additional Positive Findings For APOPTONE&trade; (HE3235) In Preclinical Models Of Castration-Resistant Prostate Cancer
http://www.medicalnewstoday.com/articles/123770.php
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today presented new findings that suggest APOPTONE&trade; (HE3235) is inhibiting in preclinical models of castration-resistant prostate cancer, the ability of tumors to synthesize the hormones necessary for their survival, as well as significantly down regulating the androgen receptor.

Scientists Establish New Blood Test To Better Evaluate Prostate Cancer
http://www.medicalnewstoday.com/articles/123720.php
An international study led by researchers at The Institute of Cancer Research will pave the way for a test to be used to better tailor treatments and hopefully extend the survival of men with aggressive forms of metastatic prostate cancer.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

No comments: